Cluster of Coronavirus Disease 2019 (COVID-19) in the French Alps, February 2020
Author:
Danis Kostas1, Epaulard Olivier234, Bénet Thomas5, Gaymard Alexandre6, Campoy Séphora7, Botelho-Nevers Elisabeth89ORCID, Bouscambert-Duchamp Maude6, Spaccaferri Guillaume5, Ader Florence10, Mailles Alexandra1, Boudalaa Zoubida7, Tolsma Violaine11, Berra Julien7, Vaux Sophie1, Forestier Emmanuel12, Landelle Caroline1314, Fougere Erica5, Thabuis Alexandra5, Berthelot Philippe89, Veil Raphael15, Levy-Bruhl Daniel1, Chidiac Christian1016, Lina Bruno6, Coignard Bruno1, Saura Christine5, Brottet Elise, Casamatta Delphine, Gallien Yves, George Scarlett, Viriot Delphine, Ait Belghiti Fatima, Bernard-Stoecklin Sibylle, Desenclos Jean-Claude, Giese Coralie, Ghislain Didier, Gounon Magali, Grangeret Nathalie, Marie Cécile, Morel Bruno, Deher Muriel, Ronnaux Baron Anne-Sophie, Courbis Geneviève, Ragozin Nathalie, Wolska Monika, Serange Eric, Mercatello Delphine, Aiouaz Soraya, Valette Martine, Frobert Emilie, Josset Laurence, Escuret Vanessa, Morfin Florence, Billaud Geneviève, Blanc Myriam, Arata-Bardet Julie, Froidure Marie, Le Maréchal Marion, Pavese Patricia, Pierre Isabelle, Becker Agathe, Chauvelot Pierre, Conrad Anne, Ferry Tristan, Miailhes Patrick, Perpoint Thomas, Pouderoux Cécile, Roux Sandrine, Valour Florent, Lutz Marie-France, Pouvaret Anne, Vitrat Virginie, Maillet Mylène, Janssen Cécile, Piet Emilie, Bosch Alexie, Destrem Anne-Laure, Isnard Margaux, Challan-Belval Thibault, Wackenheim Chloe, Couturier Alice, Gheno Gael, Roupioz Thierry, Lucet Nicolas, Ayouni Stéphane, Vincent Mireille, de Epidemiología Servicio, General de Salud Pública del Gover Balear Dirección, Masserey Spicher Virginie, Bourquin Catherine, Stoll Jeanine, Chaud Pascal, Mounayar Anne-Laure,
Affiliation:
1. French National Public Health Agency, Department of Infectious Diseases, Saint-Maurice, France 2. Infectious Diseases Department, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France 3. Fédération d’infectiologie multidisciplinaire de l’Arc Alpin, Université Grenoble Alpes, Grenoble, France 4. Unité Mixte de Recherche 5075 (UMR 5075), Institut de biologie structurale, Grenoble, France 5. French National Public Health Agency, Auvergne-Rhône-Alpes Regional Office, Lyon, France 6. Department of Virology, Infective Agents Institute, National Reference Center for Respiratory Viruses North Hospital Network, Lyon, France 7. Regional Health Agency of Auvergne Rhône Alpes, Lyon, France 8. Infectious Diseases Department, University Hospital of Saint-Etienne, Lyon, France 9. Groupe Immunité des Muqueuses et Agents Pathogènes, Université Jean Monnet, Université de Lyon, St-Etienne, France 10. Infectious and Tropical Disease Department, Croix-Rousse Hospital, University Hospital of Lyon, Lyon, France 11. Infectious Diseases Unit, Centre Hospitalier Annecy Genevois, Annecy, France 12. Infectious Disease Department, Centre Hospitalier Metropole Savoie, Chambery, France 13. Service d’Hygiène Hospitalière et de Gestion des Risques, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France 14. Techniques de l’Ingénierie Médicale et de la Complexité - Informatique, Mathématiques, Applications, Grenoble, Unité Mixte de Recherche 5525 (TIMC-IMAG UMR5525), CNRS, Université Grenoble Alpes, Grenoble, France 15. Public Health Emergency Operations Center, French Ministry of Health, Paris, France 16. Maladies Infectieuses et Tropicales, Université Claude Bernard Lyon 1 (UCBL1), Unité de formation et de recherche (UFR) Lyon Sud–Charles Mérieux, Lyon, France
Abstract
Abstract
Background
On 7 February 2020, French Health authorities were informed of a confirmed case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an Englishman infected in Singapore who had recently stayed in a chalet in the French Alps. We conducted an investigation to identify secondary cases and interrupt transmission.
Methods
We defined as a confirmed case a person linked to the chalet with a positive reverse-transcription polymerase chain reaction sample for SARS-CoV-2.
Results
The index case stayed 4 days in the chalet with 10 English tourists and a family of 5 French residents; SARS-CoV-2 was detected in 5 individuals in France, 6 in England (including the index case), and 1 in Spain (overall attack rate in the chalet: 75%). One pediatric case, with picornavirus and influenza A coinfection, visited 3 different schools while symptomatic. One case was asymptomatic, with similar viral load as that of a symptomatic case. Seven days after the first cases were diagnosed, 1 tertiary case was detected in a symptomatic patient with from the chalet a positive endotracheal aspirate; all previous and concurrent nasopharyngeal specimens were negative. Additionally, 172 contacts were monitored; all contacts tested for SARS-CoV-2 (N = 73) were negative.
Conclusions
The occurrence in this cluster of 1 asymptomatic case with similar viral load as a symptomatic patient suggests transmission potential of asymptomatic individuals. The fact that an infected child did not transmit the disease despite close interactions within schools suggests potential different transmission dynamics in children. Finally, the dissociation between upper and lower respiratory tract results underscores the need for close monitoring of the clinical evolution of suspected cases of coronavirus disease 2019.
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Microbiology (medical)
Cited by
217 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|